NM_182961.4:c.9091A>G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_182961.4(SYNE1):c.9091A>G(p.Arg3031Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000576 in 1,614,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3031S) has been classified as Uncertain significance.
Frequency
Consequence
NM_182961.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive ataxia, Beauce typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
 - arthrogryposis multiplex congenita 3, myogenic typeInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - Emery-Dreifuss muscular dystrophy 4, autosomal dominantInheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina
 - autosomal dominant Emery-Dreifuss muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - autosomal recessive myogenic arthrogryposis multiplex congenitaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SYNE1 | NM_182961.4  | c.9091A>G | p.Arg3031Gly | missense_variant | Exon 57 of 146 | ENST00000367255.10 | NP_892006.3 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.000302  AC: 46AN: 152234Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.0000877  AC: 22AN: 250970 AF XY:  0.0000590   show subpopulations 
GnomAD4 exome  AF:  0.0000322  AC: 47AN: 1461794Hom.:  0  Cov.: 31 AF XY:  0.0000289  AC XY: 21AN XY: 727194 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.000302  AC: 46AN: 152352Hom.:  0  Cov.: 31 AF XY:  0.000255  AC XY: 19AN XY: 74496 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:4 
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
- -
- -
not specified    Uncertain:1 
- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant    Uncertain:1 
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 3038 of the SYNE1 protein (p.Arg3038Gly). This variant is present in population databases (rs144643941, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 393008). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at